Literature DB >> 16475024

Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.

Kouji Katabami1, Hiromi Mizuno, Rikio Sano, Yuta Saito, Masaharu Ogura, Saotomo Itoh, Tsutomu Tsuji.   

Abstract

The invasive and metastatic potentials of hepatocellular carcinoma (HCC) are positively correlated with the expression level of alpha3beta1 integrin, a high-affinity adhesion receptor for laminin isoforms. Transforming growth factor (TGF)-beta1 stimulates non-invasive HCC cells to acquire invasive phenotypes in association with the enhanced expression of alpha3 integrin. In this study, we investigated the molecular mechanism underlying the upregulation of alpha3beta1 integrin by TGF-beta1 in non-invasive HepG2 HCC cells. The treatment of HepG2 cells with TGF-beta1 induced the expression of alpha3 integrin and potentiated these cells to adhere to laminin-5 and to migrate through laminin-5-coated membranes. The promoter activity was measured by luciferase assay with a series of deletion constructs of the 5'-flanking region of the mouse alpha3 integrin gene, and the results showed that the -260/-119 region (relative to the major transcription start site) contained elements responsive to TGF-beta1 stimulation. The introduction of mutations into the putative consensus binding sequence for the Ets-family of transcription factors located at -133 greatly decreased the promoter activity responding to TGF-beta1 stimulation. The nuclear proteins extracted from TGF-beta1-stimulated HepG2 cells yielded a larger amount of DNA-nuclear protein complexes than did those extracted from unstimulated cells, as determined by an electrophoretic mobility shift assay using an oligonucleotide containing the Ets-site as a probe. These results suggest that TGF-beta1 stimulates HepG2 cells to express a higher level of alpha3 integrin by transcriptional upregulation via Ets transcription factors and to exhibit a more invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475024     DOI: 10.1007/s10585-005-5260-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  50 in total

1.  The TRANSFAC system on gene expression regulation.

Authors:  E Wingender; X Chen; E Fricke; R Geffers; R Hehl; I Liebich; M Krull; V Matys; H Michael; R Ohnhäuser; M Prüss; F Schacherer; S Thiele; S Urbach
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

Review 3.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

4.  Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression.

Authors:  K Miyake; S Kimura; M Nakanishi; A Hisada; M Hasegawa; S Nagao; Y Abe
Journal:  J Neuropathol Exp Neurol       Date:  2000-01       Impact factor: 3.685

Review 5.  Fibrogenesis. V. TGF-beta signaling pathways.

Authors:  R G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

6.  Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.

Authors:  Hiromichi Ito; Mark Duxbury; Eric Benoit; Thomas E Clancy; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

7.  Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells.

Authors:  S Kagami; T Kuhara; K Yasutomo; K Okada; K Löster; W Reutter; Y Kuroda
Journal:  Exp Cell Res       Date:  1996-11-25       Impact factor: 3.905

8.  Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains.

Authors:  R N Tamura; H M Cooper; G Collo; V Quaranta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  A large cell-adhesive scatter factor secreted by human gastric carcinoma cells.

Authors:  K Miyazaki; Y Kikkawa; A Nakamura; H Yasumitsu; M Umeda
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Autocrine transforming growth factor beta 1 modulates the expression of integrin alpha 5 beta 1 in human colon carcinoma FET cells.

Authors:  D Wang; G H Zhou; T M Birkenmeier; J Gong; L Sun; M G Brattain
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  9 in total

1.  Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.

Authors:  Go Kamoshida; Ayaka Matsuda; Risa Miura; Yuri Takashima; Arisa Katsura; Tsutomu Tsuji
Journal:  Clin Exp Metastasis       Date:  2012-09-29       Impact factor: 5.150

2.  Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.

Authors:  Rui Yi; Yao Li; Feiliang Wang; Jianguo Gu; Tomoya Isaji; Jian Li; Ruomei Qi; Xiaoquan Zhu; Yanyang Zhao
Journal:  Tumour Biol       Date:  2016-02-12

Review 3.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Authors:  Ju Dong Yang; Ikuo Nakamura; Lewis R Roberts
Journal:  Semin Cancer Biol       Date:  2010-10-12       Impact factor: 15.707

4.  Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.

Authors:  Ranjan Prasad Devbhandari; Guo-Ming Shi; Ai-Wu Ke; Fei-Zhen Wu; Xiao-Yong Huang; Xiao-Ying Wang; Ying-Hong Shi; Zhen-Bin Ding; Yang Xu; Zhi Dai; Jia Fan; Jian Zhou
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

5.  Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.

Authors:  Max T Geisinger; Randy Astaiza; Tiffany Butler; Steven N Popoff; Sonia Lobo Planey; John A Arnott
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

6.  TGF‑β1 affects the renal cancer miRNome and regulates tumor cells proliferation.

Authors:  Karolina Hanusek; Beata Rybicka; Piotr Popławski; Anna Adamiok-Ostrowska; Katarzyna Głuchowska; Agnieszka Piekiełko-Witkowska; Joanna Bogusławska
Journal:  Int J Mol Med       Date:  2022-02-18       Impact factor: 4.101

7.  TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model.

Authors:  Guo-Cai Li; Qing-Hai Ye; Qiong-Zhu Dong; Ning Ren; Hu-Liang Jia; Lun-Xiu Qin
Journal:  J Exp Clin Cancer Res       Date:  2012-11-14

8.  Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice.

Authors:  Guocai Li; Lunxiu Qin; Qinghai Ye; Qiongzhu Dong; Ning Ren; Huliang Jia
Journal:  Exp Ther Med       Date:  2012-10-18       Impact factor: 2.447

9.  β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.

Authors:  Xin-Xia Feng; Mei Liu; Wei Yan; Zhen-Zhen Zhou; Yu-Jia Xia; Wei Tu; Pei-Yuan Li; De-An Tian
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.